Journal article
Detection of a genetically related carbapenemase-producing E. coli ST167 in clinical and environmental isolates: Evidence for clonal spread of CPEs across humans and the environment in Iowa, United States
Journal of global antimicrobial resistance, Vol.42, pp.154-160
05/2025
DOI: 10.1016/j.jgar.2025.02.021
PMCID: PMC12513237
PMID: 40054522
Abstract
Highlights•Environmental NDM-5 producing E. coli was detected with extensive drug-resistance. •BO1 shared only 1 – 12 SNPs with clinical strains, implying clonal spread. •Clonal spread between human and environment highlights need for strict CPE control.
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are listed by the World Health Organization as one of the critical priority pathogens needing urgent attention to address global resistance to antimicrobials. Thus, the transmission and epidemiology of CPEs need to be studied in One-Health perspectives.
Method: One environmental CPE, referred to as BO1, was isolated from a creek in Northwest Iowa, using Colilert system. Presence of carbapenemase was examined by mCIM test, and then phenotypic resistance was determined using Sensititre™ Complete Automated AST System. Whole-genome sequencing was performed and analyzed to compare with clinical CPEs.
Result and discussion: BO1, carrying blaNDM-5 was isolated from a creek in Northwest Iowa. BO1 exhibited resistance to 15 antimicrobials, defined as an extensively drug-resistant organism. BO1 was identified as ST167, which is well known as an emerging high-risk clone. IncFIA and IncQ1 types of conjugatable plasmids were identified in the BO1 genome. The genetic environment of blaNDM-5 was highly conserved as blaNDM-bleMBL-trpF-dsbD in all strains studied. Interestingly, single nucleotide polymorphism (SNP) analysis revealed BO1 shared only 1, 4 and 12 SNPs with three different clinical strains from patients at Iowa healthcare facilities.
Conclusion: The occurrence of BO1 was temporally and spatially close to that of one clinical strain, IA0018, implying the clonal spread of CPEs among humans and the environment, although the source and directionality of this spread remains unknown. This report illustrates the need for the strict control of CPEs in healthcare facilities and continuous surveillance in clinical and environmental settings to trace and prevent CPE transmission.
Details
- Title: Subtitle
- Detection of a genetically related carbapenemase-producing E. coli ST167 in clinical and environmental isolates: Evidence for clonal spread of CPEs across humans and the environment in Iowa, United States
- Creators
- Hanseob Shin - University of IowaDavid M Cwiertny - University of IowaMegan J NelsonRyan T Jepson - University of IowaMichael A Pentella - University of IowaDarrin A Thompson - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Journal of global antimicrobial resistance, Vol.42, pp.154-160
- DOI
- 10.1016/j.jgar.2025.02.021
- PMID
- 40054522
- PMCID
- PMC12513237
- NLM abbreviation
- J Glob Antimicrob Resist
- ISSN
- 2213-7165
- eISSN
- 2213-7173
- Publisher
- ELSEVIER SCI LTD
- Grant note
- University of Iowa Center for Health Effects of Environmental Contamination (CHEEC)Chicago Community Foundation at the recom-mendation of The Builders Initiative
Funding This research was supported by funding from the University of Iowa Center for Health Effects of Environmental Contamination (CHEEC) , and the Chicago Community Foundation at the recom-mendation of The Builders Initiative.
- Language
- English
- Electronic publication date
- 03/05/2025
- Date published
- 05/2025
- Academic Unit
- Central Control Hygienic Laboratory; Center for Health Effects of Environmental Contamination; Civil and Environmental Engineering; Occupational and Environmental Health; Epidemiology; Hygienic Laboratory - Bdc; Chemistry; Chemical and Biochemical Engineering
- Record Identifier
- 9984798360502771
Metrics
33 Record Views